Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Understand how tax efficiency varies among total market funds, and what factors influence after-tax returns for retirement investing.
28,571 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Foreclosure activity in April 2026 declined from March yet posted a double-digit year-over-year gain, underscoring on...
Investors react to a key vote in the semiconductor space as IonQ jumps on the SkyWater deal. Here’s what it means for...
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
DFCF's uninterrupted monthly payouts since 2021 have drawn retirees to a fixed-income strategy. The ETF blends high-q...
Five AI hyperscalers are funding a global data-center boom with bonds, signaling a trillion-dollar shift in how Big T...
Saudi Aramco’s chairman presses policymakers to embrace energy realism as global markets wrestle with supply risks an...
Looking for a meaningful tech stock investment with a modest starting stake? Here is a practical case for Uber as the...
In Japan, thousands of older workers sit near windows in near-idle roles as Western bosses push for AI and tighter pr...
A leading billionaire wealth adviser warns that America risks a 100% completely unsustainable society as wealth conce...
Former President Donald Trump says he will attend an NBA Finals game at Madison Square Garden after an invitation fro...
Colgate-Palmolive topped earnings expectations and posted stronger cash flow, positioning it as a top defensive pick ...